万泰生物：九价宫颈癌疫苗二期扩产建设项目延期至明年12月

Core Viewpoint - Wanta Bio announced the postponement of the "Phase II Expansion Project for the Nine-Valent Cervical Cancer Vaccine" to December 2026, without changes to the implementation entity, location, or investment scale [1] Group 1 - The company's board of directors approved the proposal to delay the project [1] - The postponement does not involve any changes to the use of raised funds [1] - There is no need to submit the proposal for shareholder meeting approval [1]